Genmab — Januar 2015
-
Så de har nok ikke covered i går dvs. de har stadig 600.000 stk. at cover før i dag, og omsætningen idager begrænset
-
Nu er det euopas 2 største hedgefunde så deres genmab postion er som en nål i en høstak. tror knap de kan mærke det
-
selvom de selvfølgelig ikke er tilfredse
-
De har råd til at investere http://medwatch.dk/Medicinal___Biotek/article7373520.ece
Det kan være shorterne så vågner op...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind